Video

Leiomyosarcoma Patient Discusses Treatment Roadmap, Challenges

Author(s):

Lauren Santye, Assistant Editor

Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.

Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Type 1 diabetes -- Image credit: daniiD | stock.adobe.com
Related Content
X-ray 3D visualization of lungs with tumors | Image Credit: © Moon Story - stock.adobe.com
August 8th 2025

Zongertinib Approved by FDA for Patients With Nonsquamous NSCLC With HER2 TKD Mutations

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 8th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Targeting Tumors: New Weapons in Gastrointestinal Cancer Therapy
August 8th 2025

Targeting Tumors: New Weapons in Gastrointestinal Cancer Therapy

Michael Vessicchio, PharmD
Pharmacy Times, Pharmacy Focus Oncology Edition
August 8th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Coffee and tea -- Image credit: yaisirichai | stock.adobe.com
August 8th 2025

Caffeine Consumption Not Associated With Chronic Kidney Disease, Study Finds

Gillian McGovern, Associate Editor
leaky gut syndrome abstract 3d illustration
August 8th 2025

Larazotide Safe, Effective in Children With COVID-19-Related MIS-C

Luke Halpern, Assistant Editor